Catalog Number 3095040 |
Device Problems
Fluid/Blood Leak (1250); Device Damaged Prior to Use (2284)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 02/25/2024 |
Event Type
malfunction
|
Event Description
|
Ampoule broken.It was reported that before the surgery, the packing was opened (the packing is good), noted the ampoule was broken, and there was liquid flowing out.Another device was used to complete the surgery.There were no adverse consequences to the patient.No additional information could be provided.
|
|
Manufacturer Narrative
|
Product complaint (b)(4) dmf# - 13704 trade name ¿ gentamicin sulphate active ingredient(s) ¿ gentamicin sulphate dosage form - powder strength ¿ 1.0g active in our cements.G4: no 510k as device is not marketed in the united states under this product code, but the same/similar product is marketed in the us under a different product code.This report is being submitted pursuant to the provisions of 21 cfr, part 803 (and/or part 4, as applicable).This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by depuy synthes, or its employees that the report constitutes an admission that the product, depuy synthes, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
|
|
Manufacturer Narrative
|
Product complaint (b)(4).Investigation summary ampoule broken.It was reported that before the surgery, opened the packing (the packing is good), noted the ampoule was broken, and there was liquid flowing out (as the photo shows).Another device was used to complete the surgery.There were no adverse consequences to the patient.No additional information could be provided.The product was not returned to depuy synthes, however photos were provided for review.See attachment (b)(4).The photo investigation revealed that the amber vial is damaged, which may have caused the liquid to spill into the same packaging.Once the product leaves depuy synthes control, it is unknown what environment conditions the packaged products are exposed to during that time.Therefore the suspected cause is traced to transport/storage outside of depuy synthes control.The received condition of the device confirmed the reported allegation.Since the device was not returned, a dimensional inspection cannot be performed.The overall complaint was confirmed as the observed condition of the smart set ghv gentamicin 40g would contribute to the complained device issue.Based on the investigation findings it has been determined that no corrective and/or preventative action is proposed.There is no indication that a design or manufacturing issue has caused the complaint condition.As part of depuy synthes quality process, all devices are manufactured, inspected, and released to approved specifications.Additional monitoring for any potential safety signals will be conducted through complaint trending and other post-market safety surveillance activities.Device history lot a review of the dhr has confirmed that there were no process issues documented that could contribute to the event described.H10 additional narrative: added: b5.
|
|
Event Description
|
Additional information received: a.Was there any surgical delay related to the event? no surgical delay.B.How was the cement prepared for use? opening the packaging, it was found that the ampoule was broken, so the cement was not used.
|
|
Search Alerts/Recalls
|
|